This cohort study examines if rates of overtreatment of men with prostate cancer with limited life expectancy have persisted in the active surveillance era and whether overtreatment varies by tumor risk or treatment type.
Key PointsA 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia.The CCRS offers precise CCUS risk assessment for p
Nature Communications – Using clinico-genomic data from 78,287 cancer patients, this study identifies genomic alterations linked to survival outcomes, advancing precision oncology by predicting…
Nature – DNA damage caused by a high-fat diet can increase the risk of tumour formation in the liver.
The phase 2 TROPiCS-03 study evaluated the efficacy/safety of sacituzumab govitecan (SG) as second-line treatment in patients with previously treated extensive-stage small cell lung cancer…
Gene therapy for Diamond-Blackfan anemia is constrained by dozens of causative mutations. Voit and colleagues develop a universal gene therapy through erythroid-lineage-restricted expression of GATA1…
Key Points. SOC cilta-cel in RRMM results in deep and durable response despite over half the patients not meeting CARTITUDE-1 eligibility criteria.Close su
This cross-sectional study evaluates contemporary patterns of lipoprotein a testing among US veterans receiving care through the Veterans Health Administration.
Nature Medicine – In a comprehensive dataset from 3,652 patients across 20 centers in eight countries, an ultrasound-based AI model shows robust performance across centers,…
This cohort study evaluates the prevalence of dementia diagnoses among US adults with autism spectrum disorder.
Vivek Subbiah: The NEJM Group 2024 Notable Articles collection is out / cancer, NEJM, New England Journal of Medicine, Notable Articles, OncoDaily, Oncology,
